Haitao Xiao Selected Research

Haitao Xiao Research Topics

Disease

9	Colitis 07/2023 - 01/2016
9	Neoplasms (Cancer) 01/2022 - 10/2009
5	Wounds and Injuries (Trauma) 09/2023 - 10/2009
5	Inflammation (Inflammations) 01/2023 - 05/2019
3	Obesity 12/2023 - 01/2022
3	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2023 - 01/2020
3	Infections 09/2023 - 09/2009
3	Body Weight (Weight, Body) 06/2023 - 01/2022
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 10/2022 - 09/2021
2	Brain Injuries (Brain Injury) 06/2024 - 05/2019
2	Neuroinflammatory Diseases 06/2024 - 05/2019
2	Diarrhea 11/2023 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2023 - 01/2022
2	Ulcer 05/2022 - 01/2022
2	Keloid 01/2021 - 01/2018
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 01/2021
2	Fibrosis (Cirrhosis) 01/2021 - 01/2013
2	Contracture 06/2019 - 03/2016
2	Cicatrix (Scar) 06/2019 - 03/2016
1	Ulcerative Colitis 01/2023
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023
1	Dysbiosis 01/2023
1	Insulin Resistance 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Non-alcoholic Fatty Liver Disease 10/2022
1	Foreign Bodies (Foreign Body) 02/2022
1	Burns 01/2022
1	Pressure Ulcer (Bedsore) 01/2022
1	Rhabdomyosarcoma 01/2022
1	Weight Loss (Weight Reduction) 01/2022
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2022
1	Psoriasis (Pustulosis Palmaris et Plantaris) 11/2021
1	Skin Neoplasms (Skin Cancer) 11/2021
1	Melanoma (Melanoma, Malignant) 11/2021
1	Localized Scleroderma (Morphea) 09/2021

Drug/Important Bio-Agent (IBA)

5	CytokinesIBA 01/2022 - 03/2019
4	Dextran SulfateIBA 07/2023 - 01/2022
4	Therapeutic UsesIBA 01/2023 - 10/2009
3	GlycosidesIBA 06/2024 - 05/2019
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 06/2023 - 01/2021
3	Interleukin-6 (Interleukin 6)IBA 01/2023 - 01/2022
3	Type II Tumor Necrosis Factor ReceptorsIBA 10/2016 - 06/2014
2	Neuroprotective AgentsIBA 06/2024 - 05/2019
2	IridoidsIBA 06/2024 - 05/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2022
2	Polysaccharides (Glycans)IBA 10/2022 - 02/2022
2	AdiponectinIBA 01/2022 - 08/2015
2	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021 - 06/2014
2	Fluorouracil (Carac)FDA LinkGeneric 01/2021 - 03/2019
1	NF-kappa B (NF-kB)IBA 06/2024
1	Estrogens (Estrogen)FDA Link 12/2023
1	bis(4-hydroxyphenyl)sulfoneIBA 12/2023
1	Serotonin (5 Hydroxytryptamine)IBA 11/2023
1	Claudin-3IBA 06/2023
1	picroside-IIIIBA 06/2023
1	OccludinIBA 06/2023
1	Claudin-2IBA 06/2023
1	Circular RNAIBA 01/2023
1	Adenosine Diphosphate (ADP)IBA 01/2023
1	Galectin 1 (LGALS1)IBA 01/2023
1	MicroRNAs (MicroRNA)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2023
1	phenethylamineIBA 01/2023
1	LigandsIBA 01/2023
1	tryptamineIBA 01/2023
1	Tryptophan (L-Tryptophan)FDA Link 12/2022
1	perchlorateIBA 10/2022
1	OrganophosphatesIBA 10/2022
1	HerbicidesIBA 10/2022
1	PhenolsIBA 10/2022
1	NitratesIBA 10/2022
1	thiocyanateIBA 10/2022
1	Pyrethrins (Pyrethroids)FDA Link 10/2022
1	Polychlorinated Dibenzodioxins (TCDD)IBA 10/2022
1	HydrocarbonsIBA 10/2022
1	Starch (Cornstarch)IBA 10/2022
1	HydrogelsIBA 02/2022
1	entrectinibIBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	PlasticsIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	TeaIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Anti-Obesity Agents (Antiobesity Drugs)IBA 01/2022
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022
1	PerforinIBA 01/2022
1	PhytochemicalsIBA 09/2021
1	CollagenIBA 09/2021

Therapy/Procedure

8	Therapeutics 09/2023 - 09/2009
3	Free Tissue Flaps 05/2022 - 01/2016
3	Perforator Flap 01/2022 - 03/2016
2	Myocutaneous Flap 01/2022 - 10/2009
2	Radiotherapy 01/2021 - 01/2018
1	Tissue Expansion Devices (Tissue Expander) 05/2022
1	Transplantation 05/2022
1	Duration of Therapy 01/2022
1	Immunotherapy 01/2022
1	Precision Medicine 01/2022
1	Biological Therapy 11/2021